April 2016

The Elizabeth Glaser Pediatric AIDS Foundation Mourns Loss of Leader, Colleague, Friend, Dr. Anthony Tanoh


Media Contacts: Ryan Henson: rhenson@pedaids.org or +1 (202) 280-1537

Washington, D.C.—April 4, 2016— The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) expresses deep sadness at the loss of longtime colleague, leader, and friend, Dr. Anthony Tanoh. The news came early this morning that Dr. Tanoh had fallen ill late last week and passed away on Sunday evening, April 3 in Abidjan, Côte d’Ivoire.

For the last five years Dr. Tanoh had served as Executive Director of Fondation Ariel Glaser pour la Lutte contre le Sida Pédiatrique, EGPAF’s ARIEL affiliate organization in Côte d’Ivoire, where he oversaw lifesaving work and programs that reached countless children, mothers and families living with HIV. Dr. Tanoh first joined the EGPAF team in 2004 through the CDC funded Project HEART, and previously worked with the Ministry of Health in Côte d’Ivoire.

“Anthony was a man of remarkable dedication, passion and vision who dedicated his life’s work to the health of his country. He was absolutely instrumental to the success of EGPAF’s mission in Côte d’Ivoire, through his time as an EGPAF staff member and especially through his leadership of Fondation Ariel Glaser,” said Charles Lyons, EGPAF President and CEO. “The sudden loss of such an indispensable leader and friend will be felt acutely by those who knew and worked with him, and who will remember him with the fondness and admiration that I do.  He will be dearly missed.”

EGPAF offers our deepest condolences to Dr. Tanoh’s family, friends, and the staff of Fondation Ariel Glaser, as they try to absorb and cope with this shocking news in the days and weeks to come. Dr. Anthony Tanoh is survived by his wife, Sidonie Grah, and three young boys and by his enduring legacy of commitment to the health and happiness of the people of Côte d’Ivoire.


About the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF):
EGPAF is the global leader in the fight against pediatric HIV/ AIDS and has reached nearly 23 million women with services to prevent transmission of HIV to their babies. It currently supports more than 6,000 health facilities and works in 14 countries to implement prevention, care, and treatment services; to further advance innovative research; and to execute global advocacy activities that bring dramatic change to the lives of millions of women, children, and families worldwide. For more information, visit www.pedaids.org.